In this session, speakers discuss the clinical considerations essential for effective consultations and prescribing in transgender individuals living with cancer.
The session delves into creating a supportive environment during consultations, emphasising inclusive language, respectful pronoun usage, patient confidentiality, and accurate record-keeping. Additionally, it explores gender affirming care and its potential implications on pharmacokinetics, drug interactions and adverse effects.

Learning outcomes:
Attendees will learn more about conducting inclusive consultations, deepening patient trust, and encouraging disclosure of essential information that is crucial for safe and effective prescribing within this minority population.